142 related articles for article (PubMed ID: 29921723)
1. EurA1c: The European HbA1c Trial to Investigate the Performance of HbA1c Assays in 2166 Laboratories across 17 Countries and 24 Manufacturers by Use of the IFCC Model for Quality Targets.
EurA1c Trial Group
Clin Chem; 2018 Aug; 64(8):1183-1192. PubMed ID: 29921723
[TBL] [Abstract][Full Text] [Related]
2. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system.
Kaiser P; Spannagl M; van Campenhout C; Lenga Y; Siebelder C; Weykamp C
Clin Chem Lab Med; 2016 Nov; 54(11):1769-1775. PubMed ID: 27171390
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Performance of Laboratories and Manufacturers Within the Framework of the IFCC model for Quality Targets of HbA1c.
Weykamp C; Siebelder C
J Diabetes Sci Technol; 2018 Jul; 12(4):747-752. PubMed ID: 29145735
[TBL] [Abstract][Full Text] [Related]
4. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories.
Tominaga M; Makino H; Yoshino G; Kuwa K; Takei I; Aono Y; Hoshino T; Umemoto M; Shimatsu A; Sanke T; Kuwashima M; Taminato T; Ono J
Ann Clin Biochem; 2005 Jan; 42(Pt 1):41-6. PubMed ID: 15802031
[TBL] [Abstract][Full Text] [Related]
5. HbA1c: a comparison of NGSP with IFCC transformed values.
Dhatt GS; Agarwal MM; Bishawi B
Clin Chim Acta; 2005 Aug; 358(1-2):81-6. PubMed ID: 16018879
[TBL] [Abstract][Full Text] [Related]
6. Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job?
Delatour V; Clouet-Foraison N; Jaisson S; Kaiser P; Gillery P
Clin Chem Lab Med; 2019 Sep; 57(10):1623-1631. PubMed ID: 31085744
[TBL] [Abstract][Full Text] [Related]
7. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group.
; Mosca A; Goodall I; Hoshino T; Jeppsson JO; John WG; Little RR; Miedema K; Myers GL; Reinauer H; Sacks DB; Weykamp CW
Clin Chem Lab Med; 2007; 45(8):1077-80. PubMed ID: 17867998
[TBL] [Abstract][Full Text] [Related]
8. The IFCC Reference Measurement System for HbA1c: a 6-year progress report.
Weykamp C; John WG; Mosca A; Hoshino T; Little R; Jeppsson JO; Goodall I; Miedema K; Myers G; Reinauer H; Sacks DB; Slingerland R; Siebelder C
Clin Chem; 2008 Feb; 54(2):240-8. PubMed ID: 18223132
[TBL] [Abstract][Full Text] [Related]
9. Standardization of HbA1c and Optimal Range of Monitoring.
Miedema K
Scand J Clin Lab Invest Suppl; 2005; 240():61-72. PubMed ID: 16112961
[TBL] [Abstract][Full Text] [Related]
10. A review of the challenge in measuring hemoglobin A1c.
Weykamp C; John WG; Mosca A
J Diabetes Sci Technol; 2009 May; 3(3):439-45. PubMed ID: 20144280
[TBL] [Abstract][Full Text] [Related]
11. Japanese standard reference material JDS Lot 2 for haemoglobin A1c. II: Present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays.
Tominaga M; Makino H; Yoshino G; Kuwa K; Takei I; Aono Y; Hoshino T; Umemoto M; Shimatsu A; Sanke T; Kuwashima M; Taminato T; Ono J
Ann Clin Biochem; 2005 Jan; 42(Pt 1):47-50. PubMed ID: 15802032
[TBL] [Abstract][Full Text] [Related]
12. The global impact of the International Federation of Clinical Chemistry and Laboratory Medicine, Education and Management Division: engaging stakeholders and assessing HbA1c quality in a multicentre study across China.
English E; Weykamp C; Ji L; Siebelder C; Shan Z; Wang Y; Li H; Garry John W
Clin Chem Lab Med; 2018 Dec; 57(2):288-295. PubMed ID: 30044761
[TBL] [Abstract][Full Text] [Related]
13. Laboratory standardization of a large international clinical trial: the DAIS experience. DAIS Project Group. Diabetes Atherosclerosis Intervention Study.
McGuinness C; Seccombe DW; Frohlich JJ; Ehnholm C; Sundvall J; Steiner G
Clin Biochem; 2000 Feb; 33(1):15-24. PubMed ID: 10693982
[TBL] [Abstract][Full Text] [Related]
14. Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics.
Weykamp C; John G; Gillery P; English E; Ji L; Lenters-Westra E; Little RR; Roglic G; Sacks DB; Takei I;
Clin Chem; 2015 May; 61(5):752-9. PubMed ID: 25737535
[TBL] [Abstract][Full Text] [Related]
15. Best use of the recommended IFCC reference method, material and values in HbA1C analyses.
Penttilä IM; Halonen T; Punnonen K; Tiikkainen U
Scand J Clin Lab Invest; 2005; 65(6):453-62. PubMed ID: 16179278
[TBL] [Abstract][Full Text] [Related]
16. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.
Little RR; Rohlfing CL; Sacks DB;
Clin Chem; 2011 Feb; 57(2):205-14. PubMed ID: 21148304
[TBL] [Abstract][Full Text] [Related]
17. Performance of glycated hemoglobin (HbA(1c)) methods evaluated with EQAS studies using fresh blood samples: Still space for improvements.
Mosca A; Paleari R; Carobene A; Weykamp C; Ceriotti F
Clin Chim Acta; 2015 Dec; 451(Pt B):305-9. PubMed ID: 26483128
[TBL] [Abstract][Full Text] [Related]
18. Standardization of two immunological HbA1c routine assays according to the new IFCC reference method.
Groche D; Hoeno W; Hoss G; Vogt B; Herrmann Z; Witzigmann A
Clin Lab; 2003; 49(11-12):657-61. PubMed ID: 14651337
[TBL] [Abstract][Full Text] [Related]
19. HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.
Goodall I
Clin Biochem Rev; 2005 Feb; 26(1):5-19. PubMed ID: 16278773
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HbA1C results in an external quality assessment scheme in South Africa.
Dhatt GS; Pum JK; Viljoen A; Jenner W
Clin Chim Acta; 2003 May; 331(1-2):147-51. PubMed ID: 12691875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
